1 / 6

Metabolic Disorders Drugs Market Industry Trends And Emerging Opportunities Till 2030

A recent report published by The Business Research Company on Metabolic Disorders Drugs Market provides in-depth analysis of segments and sub-segments in the global as well as regional.<br>Read More @ https://bit.ly/2AArrMP

sreeramakrishnatbrc
Télécharger la présentation

Metabolic Disorders Drugs Market Industry Trends And Emerging Opportunities Till 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Metabolic Disorders Drugs Global Market Report 2020-30: COVID-19 Impact And Recovery © The Business Research Company. All rights reserved.

  2. Metabolic Disorders Drugs Market Characteristics: Click Here To View Complete Report The global metabolic disorders drugs market is expected to decline from $145.9 billion in 2019 to $141.4 billion in 2020 at a compound annual growth rate (CAGR) of -3.1%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. The pandemic is affecting industries across the globe, including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 8% from 2021 and reach $200.8 billion in 2023. The Business Research Company published its Metabolic Disorders Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Metabolic Disorders Drugs market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus. The report covers the metabolic disorders drugs market’s segments- by type: anti diabetics drugs, anti-thyroid drugs, others (hyperparathyroidism, hypopituitarism, hypoadrenalism), by distribution channel: hospital pharmacies, retail pharmacies/ drug stores, others, by route of administration: oral, parenteral, others, by drug classification: branded drugs, generic drugs, and by mode of purchase: prescription-based drugs, over-the-counter drugs. The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. © The Business Research Company. All rights reserved.

  3. Major Key Players:Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co Click Here To Get A Sample Report © The Business Research Company. All rights reserved.

  4. Table Of Content 1. Executive Summary 2. Report Structure 3. Metabolic Disorders Drugs Market Characteristics 4. Metabolic Disorders Drugs Market Product Analysis 5. Metabolic Disorders Drugs Market Supply Chain …… 20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market 21. Market Background: Pharmaceutical Drugs Market 22. Recommendations 23. Appendix 24. Copyright And Disclaimer Click Here To Get A Sample Report The Business Research Company. All rights reserved.

  5. Get In Touch Whatever your need be, at The Business Research Company we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. © The Business Research Company. All rights reserved.

  6. Americas The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info Asia The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info © The Business Research Company. All rights reserved.

More Related